S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0132
+0.0001 (0.76%)
Sep 4, 2025, 9:30 AM CET
S2Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 15.47 | 14.68 | 7.72 | 6.16 | 10.63 | 27.53 | Upgrade |
Other Revenue | -8.32 | - | - | - | - | 0.44 | Upgrade |
| 7.15 | 14.68 | 7.72 | 6.16 | 10.63 | 27.97 | Upgrade | |
Revenue Growth (YoY) | -63.44% | 90.03% | 25.39% | -42.08% | -61.98% | 399.50% | Upgrade |
Cost of Revenue | 1.84 | 0.77 | 2.69 | 0.99 | 3.54 | 17.48 | Upgrade |
Gross Profit | 5.31 | 13.91 | 5.04 | 5.17 | 7.1 | 10.48 | Upgrade |
Selling, General & Admin | 14.57 | 14.99 | 19.14 | 31.54 | 25.54 | 23.06 | Upgrade |
Other Operating Expenses | -7.21 | -7.22 | -0.57 | -0.61 | -0.1 | 1.18 | Upgrade |
Operating Expenses | 8.63 | 9.08 | 20.3 | 32.85 | 26.93 | 25.55 | Upgrade |
Operating Income | -3.32 | 4.83 | -15.26 | -27.69 | -19.84 | -15.06 | Upgrade |
Interest Expense | -0.04 | -0.02 | -7.44 | -1.77 | -0.24 | -0.07 | Upgrade |
Interest & Investment Income | 0 | 0 | 0 | - | - | 0 | Upgrade |
Other Non Operating Income (Expenses) | -0.15 | - | - | - | - | - | Upgrade |
Pretax Income | -3.51 | 4.81 | -22.71 | -29.46 | -20.08 | -15.13 | Upgrade |
Net Income | -2.76 | 4.81 | -22.71 | -29.46 | -20.08 | -15.13 | Upgrade |
Net Income to Common | -2.76 | 4.81 | -22.71 | -29.46 | -20.08 | -15.13 | Upgrade |
Shares Outstanding (Basic) | - | 560 | 121 | 24 | 15 | 12 | Upgrade |
Shares Outstanding (Diluted) | - | 560 | 121 | 24 | 15 | 12 | Upgrade |
Shares Change (YoY) | - | 360.86% | 411.02% | 60.30% | 26.41% | 3.86% | Upgrade |
EPS (Basic) | - | 0.01 | -0.19 | -1.24 | -1.35 | -1.29 | Upgrade |
EPS (Diluted) | - | 0.01 | -0.19 | -1.24 | -1.35 | -1.29 | Upgrade |
Free Cash Flow | 6.21 | 5.03 | -16.52 | -28.34 | -19.85 | -13.04 | Upgrade |
Free Cash Flow Per Share | - | 0.01 | -0.14 | -1.19 | -1.34 | -1.11 | Upgrade |
Gross Margin | 74.28% | 94.79% | 65.22% | 83.86% | 66.74% | 37.49% | Upgrade |
Operating Margin | -46.40% | 32.89% | -197.63% | -449.53% | -186.54% | -53.85% | Upgrade |
Profit Margin | -38.63% | 32.78% | -294.00% | -478.23% | -188.83% | -54.12% | Upgrade |
Free Cash Flow Margin | 86.77% | 34.28% | -213.89% | -460.08% | -186.70% | -46.64% | Upgrade |
EBITDA | -2.66 | 5.52 | -14.14 | -26.37 | -18.73 | -14.14 | Upgrade |
EBITDA Margin | -37.22% | 37.61% | -183.02% | - | -176.11% | -50.56% | Upgrade |
D&A For EBITDA | 0.66 | 0.69 | 1.13 | 1.32 | 1.11 | 0.92 | Upgrade |
EBIT | -3.32 | 4.83 | -15.26 | -27.69 | -19.84 | -15.06 | Upgrade |
EBIT Margin | -46.40% | 32.89% | -197.63% | - | -186.54% | -53.85% | Upgrade |
Revenue as Reported | 14.27 | 22.33 | 8.45 | 8.93 | 11.5 | 28.7 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.